The effect of human immunodeficiency virus (HlV)-induced thymic dysfunction (TD) on mortality was studied in 265 infected infants in the CDC Perinatal AIDS Collaborative Transmission Study. TD was defined as both CD4 and CDS T cell counts below the 5th percentile of joint distribution for uninfected infants within 6 months of life. The 40 HIV-infected infants with TD (1596) had a significantly greater mortality than did the 225 children without TD (4496 vs. 996 within 2 years). Infants with TD infected in utero had higher mortality than did those infected intrapartum (7096 vs. 3796 within 2 years), while no significant difference was noted between infants without TD with either mode of transmission. The TD profile was independent of plasma virus load. Virus-induced TD by particular HIV strains and the time of transmission are likely to explain the variation in pathogenesis and patterns of disease progression and suggest the need for early aggressive therapies for HIV-infected infants with TD. Definition of the TD profile. Flow cytometric determinations of CD3, CD4, and CDS T lymphocytes were obtained in the five laboratories associated with the PACTS group by use of conventional methods [7] . The joint distribution of CD4 and CDS lymphocytes among the 1189 HIV-exposed but uninfected PACTS children, who had at least one immunophenotypic determination in the first 6 months of life, was used to establish the thresholds for TD characterization. As in the previous study, presence of the TD profile was defined as having both CD4 and CDS cell counts below the 5th percentiles of the joint distribution graph in the 1189 HIVexposed but noninfected control children. In case of multiple im-
tion, the interrelationship of TD with other factors known to influence disease progression (timing of transmission [4] and virus load [5] ) was also examined. Validating these observations could provide useful prognostic markers that may guide early therapy with intensive antiviral, and possible immune restoration, strategies.
Materials and Methods
Study population. The CDC PACTS group has enrolled and followed prospectively children bom to HIV-infected mothers in centers located in New York City, Newark (New Jersey), Baltimore, and Atlanta since 1985. Of 1454 children enrolled by November 1996,265 (1807o) were found to be HIV-infected according to established criteria [6] . Polymerase chain reaction (PCR) test results in the first week of life, available for 113 of the infected children, were used to determine the presumptive timing of transmission. Only mortality associated with HIV, as determined by the clinical provider, was included in the analyses. All of the clinical and epidemiologic data were entered into a central computer at CDC, as described elsewhere [6] .
Definition of the TD profile. Flow cytometric determinations of CD3, CD4, and CDS T lymphocytes were obtained in the five laboratories associated with the PACTS group by use of conventional methods [7] . The joint distribution of CD4 and CDS lymphocytes among the 1189 HIV-exposed but uninfected PACTS children, who had at least one immunophenotypic determination in the first 6 months of life, was used to establish the thresholds for TD characterization. As in the previous study, presence of the TD profile was defined as having both CD4 and CDS cell counts below the 5th percentiles of the joint distribution graph in the 1189 HIVexposed but noninfected control children. In case of multiple im-munophenotypic studies from an individual available during this period, the last measurement of CD4 and CDS T lymphocyte counts was used [2] . In addition, threshold values derived from joint distribution analyses from each of the first 6 months of life were also used to determine TD status at different ages and to ascertain the earliest time this approach might prove reliable for TD identification.
HIV load assay. Plasma HIV RNA was quantified by the nucleic acid sequence-based assay (Organon Teknika, Boxtel, Netherlands) following the manufacturer's instructions.
Statistical methods. After censoring observations at loss to follow-up or non-HIV-related death, univariate times to HIVrelated mortality were described with Kaplan-Meier estimates; corresponding comparisons between groups were made with generalized Wilcoxon test statistics. Cox proportional hazards modeling was used to evaluate the independent prognostic value of the TD profile, adjusted for early PCR positivity, year of birth, and sex. All P values are unadjusted for the number of comparisons made, but conclusions regarding associations are based on adjustment for this multiplicity. Standard descriptive statistics were used to characterize virus load, and differences between groups were compared by Kruskal-Wallis one-way analysis of variance. :M814 and ^04/mm3; CDS cell counts ^04 and CD4 cell counts > 1814/mm3; and CD4 cell counts *c:1814 and CDS cell counts >904/mm3 . It can be noted that mortality within the first year was more closely related to decreases in CDS lymphocytes than in CD4 lymphocytes. The mortality rate in the group with TD was much higher than that of the group with either CD4 or CDS cell depression alone. The differences were even greater by 2 or 3 years of age. Thus, the method we used for identifying TD, which takes into account both CD4 and CDS cell counts, confers a better prognostic marker of rapid death than either low CD4 or CDS cell counts alone. Table 1 
Results

Population
Discussion
This report demonstrates, in a large cohort of prospectively followed HIV-infected children, that markers of TD are predictive of survival outcome in perinatal HIV infection. The cut points for CD4 and CDS lymphocyte subsets for defining the TD profile, based on results obtained in five laboratories, were remarkably consistent with those derived from the previous study with a much smaller cohort [2] . TD was found to occur in 1507o (9507o CI, ll07o-1907o) of infants perinatally infected with HIV. This virus-induced defect, independent of virus loads, appeared to be largely responsible for the rapid progression to death in a subset of infected children previously noted by other investigators [8] [9] [10] [11] .
Our findings implicating the thymic involvement offer a convincing explanation for some of the differences in disease progression patterns between adult and pediatric AIDS. The previous suggestion that the immune system of a child is Cumulative Proportion Surviving immature, and thus cannot respond to the infection as vigorously as does the adult system, is not supported by data indicating initial strong cellular and humoral responses in many HIV-infected children [12] or in fetuses or newborns infected with many other agents [13] . The bimodal distribution of pediatric AIDS progression, indicating that many more children follow the adults' pattern [14, 15] than follow the very rapid progression found in a subset of children [8] [9] [10] [11] , also casts doubt on age alone being the major factor. On the other hand, the single most significant difference between the pediatric and adult immune systems relates to the thymus. The fetal or neonatal thymus is pivotal in providing the developing lymphoid system with naive T cells, unlike the adult thymus, which is involuting after the lymphoid system has already been fully populated [1] . Thymic destruction would thus have a totally different impact on the integrity of the pediatric versus adult immune system. Whether the fetal, neonatal, or adult thymus is affected appears to depend on the particular HIV strains, which have been found to differ in their ability to infect the thymic epithelium and/ or interfere with thymopoiesis [16] [17] [18] [19] . Thymic infection also offers a likely explanation for the significantly different effects observed associated with the timing of transmission [4] . In utero infection caused by a virus with high affinity for the thymus would have the most impact on CD4 lymphocyte depletion, as it would have affected the thymus shortly after the initiation of thymopoiesis, around the 10th week of gestation. Since the human lymphoid system would have been partially populated with lymphocytes at birth, disruption of the thymic microenvironment by similar strains of HIV transmitted intrapartum would have less, though still severe, impact. HIV strains that do not affect the thymus, even if acquired in utero, would have only a slightly higher depletion of CD4 cells due to relatively longer exposure to virusinduced postthymic lymphocyte destruction, compared with intrapartum infection. Indeed, our data suggest that the effect
